1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Multivariate analysis of factors influencing symptomatic ICH and functional independence
Factors Mean 95% CI P Value Influencing symptomatic ICH Intraprocedural heparin ≥3000 IU 3547 ± 588 IU 2377–4718 .01 ASPECTS ≤7 6.6 ± 0.4 5.8–7.4 .001 MT attempts ≥3 3.3 ± 0.3 2.6–4.1 .002 Influencing functional independence (mRS ≤2) ASPECTS ≥8 8.4 ± 0.4 7.9–9.2 .001 MT attempts ≤2 1.9 ± 0.3 1.3–2.5 .004